22-50074302-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015166.4(MLC1):c.628G>A(p.Val210Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000613 in 1,614,100 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015166.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MLC1 | NM_015166.4 | c.628G>A | p.Val210Ile | missense_variant | 8/12 | ENST00000311597.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MLC1 | ENST00000311597.10 | c.628G>A | p.Val210Ile | missense_variant | 8/12 | 1 | NM_015166.4 | P1 | |
MLC1 | ENST00000395876.6 | c.628G>A | p.Val210Ile | missense_variant | 8/12 | 1 | P1 | ||
MLC1 | ENST00000442311.1 | c.538G>A | p.Val180Ile | missense_variant | 7/8 | 5 | |||
MLC1 | ENST00000470008.1 | n.108G>A | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.000361 AC: 55AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00110 AC: 277AN: 250868Hom.: 6 AF XY: 0.00155 AC XY: 211AN XY: 135804
GnomAD4 exome AF: 0.000638 AC: 933AN: 1461760Hom.: 15 Cov.: 31 AF XY: 0.000943 AC XY: 686AN XY: 727186
GnomAD4 genome ? AF: 0.000368 AC: 56AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74490
ClinVar
Submissions by phenotype
Megalencephalic leukoencephalopathy with subcortical cysts 1 Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Benign, criteria provided, single submitter | clinical testing | Counsyl | Mar 01, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 09, 2017 | - - |
MLC1-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 11, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Megalencephalic leukoencephalopathy with subcortical cysts Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 05, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at